These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2470192)

  • 1. Mutations in polyomavirus middle T antigen affecting tumorigenesis.
    Gelinas C; Schaffhausen B; Bockus B; Ratiarson A; Bastin M
    Virology; 1989 May; 170(1):193-200. PubMed ID: 2470192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the amino-terminal half of polyomavirus middle-T antigen indicates that this region is the binding domain for pp60c-src.
    Markland W; Smith AE
    J Virol; 1987 Feb; 61(2):285-92. PubMed ID: 2433463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminus of polyomavirus middle T antigen is required for transformation.
    Cook DN; Hassell JA
    J Virol; 1990 May; 64(5):1879-87. PubMed ID: 2157858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src-dependent and -independent pathways.
    Talmage DA; Blenis J; Benjamin TL
    Mol Cell Biol; 1988 Jun; 8(6):2309-15. PubMed ID: 2457149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
    Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
    J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
    Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
    J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.
    Brewster CE; Glover HR; Dilworth SM
    J Virol; 1997 Jul; 71(7):5512-20. PubMed ID: 9188625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.
    Matthews JT; Benjamin TL
    J Virol; 1986 May; 58(2):239-46. PubMed ID: 2422391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
    Glenn GM; Eckhart W
    J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mlt Mutation in the polyomavirus genome impairing a function of the middle T protein.
    Gelinas C; Masse S; Bastin M
    J Virol; 1984 Jul; 51(1):242-6. PubMed ID: 6328044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.
    Markland W; Cheng SH; Oostra BA; Smith AE
    J Virol; 1986 Jul; 59(1):82-9. PubMed ID: 2423706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristylation of pp60c-src is not required for complex formation with polyomavirus middle-T antigen.
    Wyss A; Kaech S; Ballmer-Hofer K
    J Virol; 1990 Oct; 64(10):5163-6. PubMed ID: 2168992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyoma virus mutant with normal transforming ability but impaired tumorigenic potential.
    Gelinas C; Chartrand P; Bastin M
    J Virol; 1982 Sep; 43(3):1072-81. PubMed ID: 6292450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.
    Talmage DA; Freund R; Young AT; Dahl J; Dawe CJ; Benjamin TL
    Cell; 1989 Oct; 59(1):55-65. PubMed ID: 2551507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.